Clinical Trial Results:
An Exploratory Phase II Study of PHA-739358 in Patients with Multiple Myeloma Harbouring the t (4;14) translocation with or without FGFR3 Expression
Summary
|
|
EudraCT number |
2007-005425-30 |
Trial protocol |
FR |
Global completion date |
21 Sep 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Jun 2016
|
First version publication date |
08 Jun 2016
|
Other versions |
|
Summary report(s) |
PH II CT WITH PHA-739358 IN PTS WITH MM HARBOURING T(4;14), EXPRESSING OR NOT FGFR3 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.